Final Program

WEDNESDAY • MAY 18 341
10:20 TB Treatment Targets, Vaccines, and Host-Directed Therapies
R. Wallis, MD, Johannesburg, South Africa
10:40 Panel Discussion
D11
BASIC • TRANSLATIONAL
SCIENTIFIC SYMPOSIUM
CME Credits Available: 2.0
ARDS AND INFLAMMATORY INJURY
Assemblies on Allergy, Immunology and Inflammation; Critical Care;
Respiratory Cell and Molecular Biology; Respiratory Structure and
Function
9:00 a.m. - 11:00 a.m. MOSCONE CENTER
Room 3006/3008 (West Building, Level 3)
Target Audience
Clinical researchers, basic scientists and clinicians interested in understanding
the inter-dependence between the innate immune response, excessive
inflammation, and acute lung injury/ARDS.
Objectives
At the conclusion of this session, the participant will be able to:
• understand the mechanisms which lead to differing outcomes in ARDS;
• learn and understand the mechanisms contributing to inflammatory
response following ALI.
Acute respiratory distress syndrome (ARDS), the most severe form of ALI, has
a mortality rate of approximately 40%, despite modern ICU care. The
importance of inflammation in initiation and progression of acute lung injury has
been previously established. Inflammasome signaling is critical in the host
defense response to infectious and non-infectious agents known to contribute to
lung pathology. Inflammatory responses are typically initiated by the innate
immune system, leading to the production of IL-1ß and IL-18, which recruit
neutrophils and monocytes to the site of infection. However, these same
cytokines and cells can damage the alveolus and impair respiratory function.
An important goal of this session is to illustrate how data derived from patient
samples and clinically relevant animal models points to a common pathway(s)
and helps to define the basic mechanisms which impacts disease outcomes in
patients
Chairing: C. Hardin, MD, PhD, Boston, MA
T. Cohen, PhD, Gaithersburg, MD
9:00 Bridging Human, Animal and In-Vitro Data
M.A. Matthay, MD, San Francisco, CA
9:20 Airway Responses to Bacterial Pathogens
A.S. Prince, MD, New York, NY
9:40 Regulation of Nod-Like Receptors in Acute Lung Injury
K.M. Ridge, PhD, Chicago, IL
10:00 RAGE and Acute Lung Injury
J. Constantin, MD, PhD, Clermont-Ferrand, France
10:20 Alveolar Epithelial Repair After Inflammatory Injury
R.L. Zemans, MD, Denver, CO
10:40 The Transcription Factor Miz1 in the Lung: Good or Bad?
J. Liu, PhD, Chicago, IL
D12
CLINICAL
SCIENTIFIC SYMPOSIUM
CME Credits Available: 2.0
ADVANCES IN TOBACCO DEPENDENCE
TREATMENT FOR THE HOSPITALIZED PATIENT
Tobacco Action Committee
9:00 a.m. - 11:00 a.m. MOSCONE CENTER
Room 130-132 (North Building, Lower Level)
Target Audience
Health care workers treating tobacco dependence and tobacco related disease.
Objectives
At the conclusion of this session, the participant will be able to:
• gain new strategies to initiate a quit attempt for hospitalized smokers;
• become familiar with the tools available to implement a hospital-based
smoking cessation program that includes post-discharge follow up;
• improve smoking cessation rates among hospitalized patients.
Hospitalization marks a unique opportunity to impact the tobacco epidemic. The
effective health care system must consider a number of variables in devising
interventions for promoting abstinence and facilitating transition to outpatient care.
In this session various aspects of tobacco dependence treatment in hospitalized
smokers will be explored. Common obstacles including initial counseling of
resistant patients, personalizing treatment plans, use of technology, and effective
discharge planning will be reviewed.
Chairing: F.T. Leone, MD, MS, Philadelphia, PA
9:00 The Inpatient Tobacco Treatment Consultation
F.T. Leone, MD, MS, Philadelphia, PA
9:25 Implementing Hospital Cessation: The Ottawa Model
S. Gilman, MD, Montreal, Canada
9:50 Initiating NRT and Other Treatments
D. Sachs, MD, Palo Alto, CA
10:15 Transitioning into Post-Discharge Care
S. Pakhale, MD, Ottowa, Canada
10:35 Should We Allow E-Cigarette Use in Hospitals?
D.J. Upson, MA, MD, Albuquerque, NM
D13
There will be a 5-minute discussion after each talk.
MINI SYMPOSIUM
VIRAL INFECTIONS AND ASTHMA: HOST DEFENSE
AND SELF DEFEAT
9:00 a.m. - 11:00 a.m. MOSCONE CENTER
Chairing: J.E. Gern, MD, Madison, WI
M.M. Wurfel, MD, PhD, Seattle, WA
T.S. Hallstrand, MD, MPH, Seattle, WA
Room 2005/2007 (West Building, Level 2)
WEDNESDAY MORNING
ATS 2016 • San Francisco